Dr Olympia Koulouri
Dr Olympia Koulouri is pleased to consider applications from prospective PhD students.
Olympia is a Clinical Lecturer in Endocrinology at the Wellcome Trust-MRC Institute of Metabolic Science.
Her PhD studies, under the supervision of Dr Mark Gurnell and Dr Nadia Schoenmakers, focused on central disorders of thyroid function.
She is particularly interested in PET imaging of the pituitary gland.
Magnetic resonance imaging (MRI)
Positron Emission Tomography (PET)
Associated News Items
Koulouri O, Hoole AC, English P, Allinson K, Antoun N, Cheow H, Burnet NG, Donnelly N, Mannion RJ, Gurnell M. (2016), “Localisation of an occult thyrotropinoma with 11C-methionine PET-CT before and after somatostatin analogue therapy.” Lancet Diabetes Endocrinol (12):1050
Koulouri O, Kandasamy N, Hoole AC, Gillett D, Heard S, Powlson AS, O'Donovan DG, Annamalai AK, Simpson HL, Akker SA, Aylwin SJ, Brooke A, Buch H, Levy MJ, Martin N, Morris D, Parkinson C, Tysome JR, Santarius T, Donnelly N, Buscombe J, Boros I, Smith R, Aigbirhio F, Antoun NM, Burnet NG, Cheow H, Mannion RJ, Pickard JD, Gurnell M. (2016), “Successful treatment of residual pituitary adenoma in persistent acromegaly following localisation by 11C-methionine PET co-registered with MRI.” Eur J Endocrinol 175(5):485-498
Koulouri O, Nicholas AK, Schoenmakers E, Mokrosinski J, Lane F, Cole T, Kirk J, Farooqi IS, Chatterjee VK, Gurnell M, Schoenmakers N. (2016), “A Novel Thyrotropin-Releasing Hormone Receptor Missense Mutation (P81R) in Central Congenital Hypothyroidism.” J Clin Endocrinol Metab 101(3):847-51
Koulouri O, Steuwe A, Gillett D, Hoole AC, Powlson AS, Donnelly NA, Burnet NG, Antoun NM, Cheow H, Mannion RJ, Pickard JD, Gurnell M. (2015), “A role for 11C-methionine PET imaging in ACTH-dependent Cushing's syndrome.” Eur J Endocrinol 173(4):M107-20
Koulouri O, Auldin MA, Agarwal R, Kieffer V, Robertson C, Falconer Smith J, Levy MJ, Howlett TA. (2011), “Diagnosis and treatment of hypothyroidism in TSH deficiency compared to primary thyroid disease: pituitary patients are at risk of under-replacement with levothyroxine.” Clin Endocrinol (Oxf) 74(6):744-9